{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:26:54Z","timestamp":1788280014307,"version":"build-2803163510"},"reference-count":66,"publisher":"Jaypee Brothers Medical Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.59556\/japi.73.0878","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:58:18Z","timestamp":1749117498000},"page":"e29-e36","source":"Crossref","is-referenced-by-count":2,"title":["Vonoprazan in Management of Refractory Gastroesophageal Reflux Disease: An Indian Expert Group Consensus Statements"],"prefix":"10.59556","volume":"73","author":[{"given":"Philip","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouradas","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SK","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SC","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Shandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molina","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GS","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateik","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Kantharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indraneel","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshid","family":"Vazifdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Borse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetam","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Bodas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smit","family":"Vaghasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar C","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Murthy","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(8):","key":"key20250605095813_B1","doi-asserted-by":"crossref","first-page":"1900.","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.","volume":"101","author":"Vakil","year":"2006;","journal-title":"Am J Gastroenterol"},{"issue":"(4):","key":"key20250605095813_B2","doi-asserted-by":"crossref","first-page":"393\u2013","DOI":"10.1016\/j.cgh.2008.02.016","article-title":"Persistent heartburn in a patient on proton-pump inhibitor.","volume":"6","author":"Fass","year":"2008;","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(1):","key":"key20250605095813_B3","doi-asserted-by":"crossref","first-page":"15\u2013","DOI":"10.1016\/j.mcna.2018.08.002","article-title":"Proton pump inhibitor-refractory gastroesophageal reflux disease.","volume":"103","author":"Yadlapati","year":"2019;","journal-title":"Med Clin North Am"},{"issue":"(5):","key":"key20250605095813_B4","doi-asserted-by":"crossref","first-page":"796\u2013","DOI":"10.1111\/jgh.16475","article-title":"A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.","volume":"39","author":"Simadibrata","year":"2024;","journal-title":"J Gastroenterol Hepatol"},{"issue":"(9):","key":"key20250605095813_B5","doi-asserted-by":"crossref","first-page":"1340.","DOI":"10.1136\/gutjnl-2011-301897","article-title":"Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.","volume":"61","author":"Sifrim","year":"2012;","journal-title":"Gut"},{"issue":"(4):","key":"key20250605095813_B6","doi-asserted-by":"crossref","first-page":"453.","DOI":"10.5056\/jnm21077","article-title":"2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease.","volume":"27","author":"Jung","year":"2021;","journal-title":"J Neurogastroenterol Motil"},{"issue":"(1):","key":"key20250605095813_B7","doi-asserted-by":"crossref","first-page":"27\u2013","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review.","volume":"11","author":"Strand","year":"2017;","journal-title":"Gut Liver"},{"issue":"(3):","key":"key20250605095813_B8","doi-asserted-by":"crossref","first-page":"153.","DOI":"10.2133\/dmpk.20.153","article-title":"Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.","volume":"20","author":"Furuta","year":"2005;","journal-title":"Drug Metab Pharmacokinet"},{"issue":"(11):","key":"key20250605095813_B9","doi-asserted-by":"crossref","first-page":"1145.","DOI":"10.1080\/14656566.2017.1346087","article-title":"Vonoprazan fumarate for the management of acid-related diseases.","volume":"18","author":"Martinucci","year":"2017;","journal-title":"Expert Opin Pharmacother"},{"issue":"(9):","key":"key20250605095813_B10","doi-asserted-by":"crossref","first-page":"928.","DOI":"10.1111\/j.1365-2036.2009.03984.x","article-title":"Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.","volume":"29","author":"Metz","year":"2009;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(1):","key":"key20250605095813_B11","doi-asserted-by":"crossref","first-page":"17\u2013","DOI":"10.5056\/jnm23145","article-title":"Refractory gastroesophageal reflux disease: diagnosis and management.","volume":"30","author":"Davis","year":"2024;","journal-title":"J Neurogastroenterol Motil"},{"issue":"(3):","key":"key20250605095813_B12","doi-asserted-by":"crossref","first-page":"334\u2013","DOI":"10.5056\/jnm18029","article-title":"Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases.","volume":"24","author":"Oshima","year":"2018;","journal-title":"J Neurogastroenterol Motil"},{"issue":"(5):","key":"key20250605095813_B13","doi-asserted-by":"crossref","first-page":"1691.","DOI":"10.1007\/s10620-023-07886-5","article-title":"Why the vonoprazan Helicobacter pylori therapies in the US-European Trial produced unacceptable cure rates.","volume":"68","author":"Graham","year":"2023;","journal-title":"Dig Dis Sci"},{"key":"key20250605095813_B14","unstructured":"CDSCO. 2023. Available at: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Gastroenterology%20&%20. CDSCO. 2023. Available at: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Gastroenterology%20&%20Hepatology%20dated%2023.05.2023.pdf. Last accessed on: 19.09.2024."},{"key":"key20250605095813_B15","unstructured":"FDA. 2022. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/215151s000lbl.pdf. Last accessed on: 19.09.2024."},{"key":"key20250605095813_B16","doi-asserted-by":"crossref","first-page":"1756283X17745776.","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.","volume":"11:","author":"Sugano","year":"2018;","journal-title":"Ther Adv Gastroenterol"},{"issue":"(7):","key":"key20250605095813_B17","doi-asserted-by":"crossref","first-page":"1158.","DOI":"10.14309\/ajg.0000000000001735","article-title":"Pharmacodynamics and pharmacokinetics of the potassium-competitive acid blocker vonoprazan and the proton pump inhibitor lansoprazole in US subjects.","volume":"117","author":"Laine","year":"2022;","journal-title":"Am J Gastroenterol"},{"issue":"(2):","key":"key20250605095813_B18","doi-asserted-by":"crossref","first-page":"249\u2013","DOI":"10.1007\/s12664-022-01333-5","article-title":"Indian consensus statements on irritable bowel syndrome in adults: a guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology.","volume":"42","author":"Ghoshal","year":"2023;","journal-title":"Indian J Gastroenterol"},{"issue":"(5):","key":"key20250605095813_B19","doi-asserted-by":"crossref","first-page":"411\u2013","DOI":"10.1007\/s12664-019-00979-y","article-title":"Indian consensus on gastroesophageal reflux disease in adults: a position statement of the Indian society of gastroenterology.","volume":"38","author":"Bhatia","year":"2019;","journal-title":"Indian J Gastroenterol"},{"issue":"(1):","key":"key20250605095813_B20","doi-asserted-by":"crossref","first-page":"7.","DOI":"10.1053\/j.gastro.2010.05.016","article-title":"Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.","volume":"139","author":"Dellon","year":"2010;","journal-title":"Gastroenterology"},{"issue":"(12):","key":"key20250605095813_B21","first-page":"62\u2013","article-title":"SGLT2i as a first-line antihyperglycemic in the management of type 2 diabetes in the context of Indians: a systematic review and consensus.","volume":"71","author":"Singh","year":"2023;","journal-title":"J Assoc Physicians India"},{"issue":"(4):","key":"key20250605095813_B22","doi-asserted-by":"crossref","first-page":"401.","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011;","journal-title":"J Clin Epidemiol"},{"issue":"(1):","key":"key20250605095813_B23","doi-asserted-by":"crossref","first-page":"27\u2013","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease.","volume":"117","author":"Katz","year":"2022;","journal-title":"Am J Gastroenterol"},{"issue":"(8):","key":"key20250605095813_B24","doi-asserted-by":"crossref","first-page":"751.","DOI":"10.1007\/s00535-016-1227-8","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.","volume":"51","author":"Iwakiri","year":"2016;","journal-title":"J Gastroenterol"},{"issue":"(9):","key":"key20250605095813_B25","doi-asserted-by":"crossref","first-page":"1402.","DOI":"10.1136\/gutjnl-2016-311715","article-title":"Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett\u2019s oesophagus.","volume":"65","author":"Fock","year":"2016;","journal-title":"Gut"},{"key":"key20250605095813_B26","first-page":"57\u2013","article-title":"Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA.","volume":"3:","author":"Stalhammar","year":"2012;","journal-title":"Pragmat Obs Res"},{"issue":"(7):","key":"key20250605095813_B27","doi-asserted-by":"crossref","first-page":"635\u2013","DOI":"10.1111\/apt.12007","article-title":"Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.","volume":"36","author":"Bytzer","year":"2012;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(3):","key":"key20250605095813_B28","doi-asserted-by":"crossref","first-page":"260.","DOI":"10.1016\/S1091-255X(01)80046-9","article-title":"Esophageal dysmotility and gastroesophageal reflux disease.","volume":"5","author":"Diener","year":"2001;","journal-title":"J Gastrointest Surg"},{"issue":"(2):","key":"key20250605095813_B29","doi-asserted-by":"crossref","first-page":"197\u2013","DOI":"10.1159\/000503340","article-title":"Clinical characterization of vonoprazan-refractory gastroesophageal reflux disease.","volume":"102","author":"Hamada","year":"2021;","journal-title":"Digestion"},{"issue":"(10):","key":"key20250605095813_B30","doi-asserted-by":"crossref","first-page":"1473.","DOI":"10.1111\/j.1365-2036.2006.02911.x","article-title":"Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.","volume":"23","author":"Gunaratnam","year":"2006;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(443):","key":"key20250605095813_B31","first-page":"463.","article-title":"Factors influencing compliance in long-term proton pump inhibitor therapy in general practice.","volume":"49","author":"Hungin","year":"1999;","journal-title":"Br J Gen Pract"},{"issue":"(1):","key":"key20250605095813_B32","doi-asserted-by":"crossref","first-page":"50.","DOI":"10.1016\/S1542-3565(05)00860-8","article-title":"Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.","volume":"4","author":"Fass","year":"2006;","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(2):","key":"key20250605095813_B33","doi-asserted-by":"crossref","first-page":"93\u2013","DOI":"10.23946\/2500-0764-2020-5-1-93-100","article-title":"Current management of proton pump inhibitor-refractory gastroesophageal reflux disease.","volume":"5","author":"Tsukanov","year":"2020;","journal-title":"Fundam Clin Med"},{"issue":"(2):","key":"key20250605095813_B34","doi-asserted-by":"crossref","first-page":"175.","DOI":"10.1016\/j.cgh.2015.04.176","article-title":"Lifestyle intervention in gastroesophageal reflux disease.","volume":"14","author":"Ness-Jensen","year":"2016;","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(1):","key":"key20250605095813_B35","first-page":"6\u2013","article-title":"Patients with refractory gastroesophageal reflux disease: diagnostic tools.","volume":"26","author":"Karamanolis","year":"2013;","journal-title":"Ann Gastroenterol"},{"issue":"(3):","key":"key20250605095813_B36","first-page":"101\u2013","article-title":"Refractory gastroesophageal reflux disease (GERD): a clinical, endoscopic, and histopathological perspective\u2013a single centre cross-sectional study.","volume":"2","author":"Verma","year":"2024;","journal-title":"Gastroenterol Endosc"},{"issue":"(Suppl 1):","key":"key20250605095813_B37","first-page":"S117.","article-title":"Findings of impedance pH-monitoring in patients with atypical gastroesophageal reflux symptoms.","volume":"6","author":"Forootan","year":"2013;","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"(4):","key":"key20250605095813_B38","doi-asserted-by":"crossref","first-page":"497\u2013","DOI":"10.5056\/jnm14038","article-title":"Diagnostic utility of impedance-pH monitoring in refractory non-erosive reflux disease.","volume":"20","author":"Khan","year":"2014;","journal-title":"J Neurogastroenterol Motil"},{"issue":"(10):","key":"key20250605095813_B39","doi-asserted-by":"crossref","first-page":"2446.","DOI":"10.1111\/j.1572-0241.2008.02033.x","article-title":"Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: \u2019on\u2019 or \u2019off\u2019 proton pump inhibitor?","volume":"103","author":"Hemmink","year":"2008;","journal-title":"Am J Gastroenterol"},{"issue":"(1):","key":"key20250605095813_B40","doi-asserted-by":"crossref","first-page":"e12556.","DOI":"10.1111\/cob.12556","article-title":"Dietary weight loss intervention provides improvement of gastroesophageal reflux disease symptoms-a randomized clinical trial.","volume":"13","author":"Valentini","year":"2023;","journal-title":"Clin Obes"},{"issue":"(3):","key":"key20250605095813_B41","doi-asserted-by":"crossref","first-page":"430.","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.","volume":"67","author":"Eusebi","year":"2018;","journal-title":"Gut"},{"issue":"(2):","key":"key20250605095813_B42","doi-asserted-by":"crossref","first-page":"284.","DOI":"10.1002\/oby.20279","article-title":"Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.","volume":"21","author":"Singh","year":"2013;","journal-title":"Obesity (Silver Spring)"},{"issue":"(Suppl 2):","key":"key20250605095813_B43","doi-asserted-by":"crossref","first-page":"109.","DOI":"10.5152\/tjg.2019.19677","article-title":"Alginates: from the ocean to gastroesophageal reflux disease treatment.","volume":"30","author":"Bor","year":"2019;","journal-title":"Turk J Gastroenterol"},{"issue":"(8):","key":"key20250605095813_B44","doi-asserted-by":"crossref","first-page":"899.","DOI":"10.1111\/apt.13567","article-title":"Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor.","volume":"43","author":"Reimer","year":"2016;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(32):","key":"key20250605095813_B45","doi-asserted-by":"crossref","first-page":"4371.","DOI":"10.3748\/wjg.v18.i32.4371","article-title":"Alginate controls heartburn in patients with erosive and nonerosive reflux disease.","volume":"18","author":"Savarino","year":"2012;","journal-title":"World J Gastroenterol"},{"issue":"(1):","key":"key20250605095813_B46","doi-asserted-by":"crossref","first-page":"e14468.","DOI":"10.1111\/nmo.14468","article-title":"Randomized clinical trial: a double-blind, proof-of-concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40\u2009mg versus esomeprazole 40\u2009mg in patients with symptomatic gastro-esophageal reflux disease and partial response to a healing dose of a proton-pump inhibitor.","volume":"35","author":"Tack","year":"2023;","journal-title":"Neurogastroenterol Motil"},{"issue":"(2):","key":"key20250605095813_B47","doi-asserted-by":"crossref","first-page":"224.","DOI":"10.1136\/gutjnl-2019-318365","article-title":"Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.","volume":"69","author":"Xiao","year":"2020;","journal-title":"Gut"},{"issue":"(6):","key":"key20250605095813_B48","doi-asserted-by":"crossref","first-page":"685.","DOI":"10.1111\/apt.13331","article-title":"Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis.","volume":"42","author":"Ashida","year":"2015;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(1):","key":"key20250605095813_B49","doi-asserted-by":"crossref","first-page":"19\u2013","DOI":"10.1007\/s10620-020-06141-5","article-title":"Direct comparison of the efficacy and safety of vonoprazan versus proton-pump inhibitors for gastroesophageal reflux disease: a systematic review and meta-analysis.","volume":"66","author":"Cheng","year":"2021;","journal-title":"Dig Dis Sci"},{"issue":"(2):","key":"key20250605095813_B50","doi-asserted-by":"crossref","first-page":"191\u2013","DOI":"10.4168\/aair.2024.16.2.191","article-title":"Potassium-competitive acid blocker versus proton pump inhibitor: a pilot study on comparable efficacy in the treatment of gastroesophageal reflux-related cough.","volume":"16","author":"Zhong","year":"2024;","journal-title":"Allergy Asthma Immunol Res"},{"issue":"(10):","key":"key20250605095813_B51","doi-asserted-by":"crossref","first-page":"1016.","DOI":"10.1111\/apt.17728","article-title":"Randomised clinical trial: efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease.","volume":"58","author":"Fass","year":"2023;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(2):","key":"key20250605095813_B52","doi-asserted-by":"crossref","first-page":"201.","DOI":"10.1007\/s10388-018-00654-9","article-title":"Efficacy of on-demand therapy using 20-mg vonoprazan for non-erosive reflux disease.","volume":"16","author":"Hoshikawa","year":"2019;","journal-title":"Esophagus"},{"issue":"(3):","key":"key20250605095813_B53","doi-asserted-by":"crossref","first-page":"252.","DOI":"10.1007\/s11894-008-0052-5","article-title":"Refractory GERD: what is it?","volume":"10","author":"Fass","year":"2008;","journal-title":"Curr Gastroenterol Rep"},{"issue":"(4):","key":"key20250605095813_B54","first-page":"196\u2013","article-title":"Treatment of refractory gastroesophageal reflux disease.","volume":"16","author":"Naik","year":"2020;","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"(6):","key":"key20250605095813_B55","doi-asserted-by":"crossref","first-page":"e94.","DOI":"10.1038\/ctg.2015.18","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of single rising TAK-438(vonoprazan) doses in healthy male Japanese\/non-Japanese subjects.","volume":"6","author":"Sakurai","year":"2015;","journal-title":"Clin Transl Gastroenterol"},{"issue":"(7):","key":"key20250605095813_B56","doi-asserted-by":"crossref","first-page":"636.","DOI":"10.1111\/apt.13121","article-title":"Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438(vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects.","volume":"41","author":"Jenkins","year":"2015;","journal-title":"Aliment Pharmacol Ther"},{"issue":"(7):","key":"key20250605095813_B57","doi-asserted-by":"crossref","first-page":"3288.","DOI":"10.1111\/bcp.15268","article-title":"Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.","volume":"88","author":"Yang","year":"2022;","journal-title":"Br J Clin Pharmacol"},{"issue":"(2):","key":"key20250605095813_B58","doi-asserted-by":"crossref","first-page":"174.","DOI":"10.1159\/000497775","article-title":"Efficacy of vonoprazan, a novel potassium-competitive acid blocker, in patients with proton pump inhibitor-refractory acid reflux.","volume":"101","author":"Akiyama","year":"2020;","journal-title":"Digestion"},{"key":"key20250605095813_B59","unstructured":"FDA. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/215151s000lbl.pdf. Last accessed on: 22.09.24."},{"issue":"(6):","key":"key20250605095813_B60","doi-asserted-by":"crossref","first-page":"589.","DOI":"10.1016\/j.coph.2005.09.001","article-title":"Gastroesophageal reflux disease.","volume":"5","author":"Armstrong","year":"2005;","journal-title":"Curr Opin Pharmacol"},{"key":"key20250605095813_B61","doi-asserted-by":"crossref","first-page":"e272.","DOI":"10.14309\/01.ajg.0000858200.17525.4a","article-title":"S390 efficacy and safety of on-demand vonoprazan versus placebo in the treatment of heartburn in symptomatic nonerosive reflux disease (NERD) patients: a phase 2 randomized controlled trial.","volume":"117:","author":"Fass","year":"2022;","journal-title":"Am J Gastroenterol"},{"key":"key20250605095813_B62","doi-asserted-by":"crossref","first-page":"2211.","DOI":"10.1016\/j.cgh.2024.05.004","article-title":"Vonoprazan is efficacious for treatment of heartburn in non-erosive reflux disease: a randomized trial.","volume":"22:","author":"Laine","year":"2024;","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(5):","key":"key20250605095813_B63","doi-asserted-by":"crossref","first-page":"803.","DOI":"10.14309\/ajg.0000000000002714","article-title":"Comparative efficacy of p-cab vs proton pump inhibitors for grade c\/d esophagitis: a systematic review and network meta-analysis.","volume":"119","author":"Zhuang","year":"2024;","journal-title":"Am J Gastroenterol"},{"issue":"(4):","key":"key20250605095813_B64","doi-asserted-by":"crossref","first-page":"344.","DOI":"10.1097\/MOG.0000000000000543","article-title":"The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.","volume":"35","author":"Scarpignato","year":"2019;","journal-title":"Curr Opin Gastroenterol"},{"issue":"(4):","key":"key20250605095813_B65","doi-asserted-by":"crossref","first-page":"570.","DOI":"10.1007\/s11938-018-0206-y","article-title":"Potent acid suppression with PPIs and P-CABs: what\u2019s new?","volume":"16","author":"Hunt","year":"2018;","journal-title":"Curr Treat Options Gastroenterol"},{"key":"key20250605095813_B66","doi-asserted-by":"crossref","first-page":"e19520.","DOI":"10.1097\/MD.0000000000019520","article-title":"Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease.","volume":"99:","author":"Gotoh","year":"2020;","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:58:30Z","timestamp":1749117510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-3-e29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.59556\/japi.73.0878"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.0878","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}